Cargando…
Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer
Research has been driven towards finding therapy predictive biomarkers for colorectal cancer (CRC) with a special interest in studying the gut microbiome. Gut microbiome acts not only as a barrier to prevent bacterial invasion and infection, but it also affects the efficacy of hematopoietic-cell tra...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747470/ https://www.ncbi.nlm.nih.gov/pubmed/31450712 http://dx.doi.org/10.3390/ijms20174155 |